Composition containing amlodipine besylate and preparation method of composition

A kind of technology of amlodipine besylate and composition, applied in the field of composition containing amlodipine besylate and the field of preparation thereof, can solve problems such as unfavorable drug dissolution, small difference in tablet weight, slow tablet disintegration and the like , to achieve the effect of reducing equipment and workshop investment, improving weight difference, and fast disintegration or dissolution

Inactive Publication Date: 2016-03-16
YICHANG HEC CHANGJIANG PHARMA CO LTD
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The tablets produced by the dry granulation and tableting process disintegrate slowly, which is not conducive to the dissolution of the drug; the usual process of the tablet process is to granulate, and the granulation process is to solve the problem of improving the fluidity of the material and making the tableting process Tablet weight difference becomes smaller
Wet granulation is generally adopted. This process is traditional, classic and reliable, but this method has many equipments, long process route and high cost. Dry granulation is to directly compress the material into solids with high pressure and break them, and sieve them into granules, which is better than wet granulation. The process is simple, but the equipment is expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition containing amlodipine besylate and preparation method of composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] A composition containing amlodipine besylate, characterized in that: said composition comprises the following components in parts by weight:

[0034] 5 parts of amlodipine besylate; 90 parts of filler; 0.4 parts of disintegrant; 1.1 parts of lubricant.

[0035] The composition is prepared as a tablet.

[0036] The filler is microcrystalline cellulose.

[0037] The disintegrant is sodium carboxymethyl starch.

[0038] Described lubricant is magnesium stearate.

[0039] The method for preparing the described composition containing amlodipine besylate is characterized in that, the method may further comprise the steps:

[0040] 1) Ingredients: weigh each component according to the prescription quantity;

[0041] 2) Premix 1: add 3 / 4 of the filler to amlodipine besylate, mix for 3 minutes, and obtain material 1;

[0042] 3) Sieving: pass material 1 through a 14-mesh sieve to obtain material 2;

[0043] 4) Premix 2: Mix material 2 for 12 minutes to obtain material 3; ...

Embodiment 2

[0051] A composition containing amlodipine besylate, characterized in that: said composition comprises the following components in parts by weight:

[0052] 5 parts of amlodipine besylate; 195 parts of filler; 2.7 parts of disintegrant; 3.1 parts of lubricant.

[0053] The composition is prepared as a tablet.

[0054] The filler is calcium hydrogen phosphate dihydrate.

[0055] The disintegrant is croscarmellose sodium.

[0056] Described lubricant is magnesium stearate.

[0057] The method for preparing the described composition containing amlodipine besylate is characterized in that, the method may further comprise the steps:

[0058] 1) Ingredients: weigh each component according to the prescription quantity;

[0059] 2) Premix 1: add 3 / 4 filler to amlodipine besylate, mix for 6 minutes, and obtain material 1;

[0060] 3) Sieving: pass material 1 through a 18-mesh sieve to obtain material 2;

[0061] 4) Premix 2: Mix material 2 for 12 minutes to obtain material 3;

...

Embodiment 3

[0069] A composition containing amlodipine besylate, characterized in that: said composition comprises the following components in parts by weight:

[0070] 5 parts of amlodipine besylate; 95 parts of filler; 0.6 parts of disintegrant; 1.3 parts of lubricant.

[0071] The composition is prepared as a tablet.

[0072] The filler is calcium hydrogen phosphate dihydrate.

[0073] The disintegrating agent is 0.2 part of croscarmellose sodium and 0.4 part of crospovidone.

[0074] Described lubricant is magnesium stearate.

[0075] The method for preparing the described composition containing amlodipine besylate is characterized in that, the method may further comprise the steps:

[0076] 1) Ingredients: weigh each component according to the prescription quantity;

[0077] 2) Premix 1: add 3 / 4 filler to amlodipine besylate, mix for 5 minutes, and obtain material 1;

[0078] 3) Sieving: pass material 1 through a 16-mesh sieve to obtain material 2;

[0079] 4) Premix 2: Mix mat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
hardnessaaaaaaaaaa
Login to view more

Abstract

The invention relates to the technical field of medicine preparation, in particular to a composition containing amlodipine besylate and a preparation method of the composition. The composition consists of the following components in parts by weight: 5 parts of amlodipine besylate, 90-195 parts of a filling agent, 0.4-2.7 parts of a disintegrating agent and 1.1-3.1 parts of a lubricating agent; and the method for preparing the composition containing the amlodipine besylate comprises the following steps: preparing materials, adding 3/4 of the filling agent to the amlodipine besylate and premixing for the first time, sieving, premixing for the second time, adding the rest 1/4 of the filling agent, premixing for the third time, adding the disintegrating agent to a material 4 and premixing for the fourth time, adding the lubricating agent and premixing for the fifth, and tabletting. According to the preparation method disclosed by the invention, the uniformly mixed powder is directly compressed into a tablet core by virtue of a tablet press; and compared with an existing wet-process granulation process, the tablet prepared by the method disclosed by the invention is dissolved out more thoroughly, simple in production process, simple in equipment, low in production cost and stable in product property, and the hardness of the tablet core is enhanced and weight difference is significantly improved.

Description

technical field [0001] The invention relates to the technical field of medicine preparation, in particular to a composition containing amlodipine besylate and a preparation method thereof. Background technique [0002] Amlodipine besylate chemical name 3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl Base-3,5-pyridinedicarboxylate benzenesulfonate, white crystal powder, soluble in methanol, slightly soluble in water. Amlodipine besylate is a commonly used drug for the treatment of hypertension and angina pectoris. It directly acts on vascular smooth muscle to reduce peripheral vascular resistance, thereby lowering blood pressure; by dilating peripheral arterioles, peripheral resistance is reduced, thereby reducing myocardial oxygen consumption, and in addition, coronary arteries and coronary arteries in normal and ischemic areas are expanded to make In patients with coronary artery spasm, the myocardial oxygen supply is increased to relieve ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/4422A61P9/12A61P9/10
CPCA61K9/2059A61K9/2054A61K9/2095A61K31/4422
Inventor 吴春华鲁科明李小芹许娄金周威胡卫国
Owner YICHANG HEC CHANGJIANG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products